Company profile - Bet site
To generate a new password, please provide the email address with which you have registered to our portal before.

After clicking the “Send” button, we will send the information about generating a new password to the specified email address.
E-mail:
Please check your inbox! We have sent the information necessary for generating a new password to the specified email address.
An error has occured. There is no user in the system with the specified e-mail address.
Please provide the email address with which you have registered to our portal before.
E-mail:
Two-factor reset email successfully sent.
Failed to send the reset email.
false
Naturland Holding Nyrt.
Naturland Holding Plc.
Naturland Holding Nyrt. A share

Naturland Holding Plc.

  • Introduction
  • Trading data
  • Financials
  • Shareholders, management
  • Publications
  • Product features
Full Name Naturland Holding Public Company Limited by Shares
Short name Naturland Holding Plc.
Sector Health care
Contact
HU-1106 Budapest, Csillagvirág utca 8.
Phone: +36-1-431-2000
Fax: -
Investor Relations
Stella Simon
Phone: +36 70 752 1844
Fax: -
Auditor KPMG Hungária Kft. (auditor: Zoltán VARGA)
Business activity As the founding owner, Naturland Holding Plc. - an asset management company - manages the strategic operations of its wholly owned subsidiary company, Naturland Hungary Ltd. The company is proud of its medium-sized pharmaceutical manufacturing culture in Hungary and its products which combine science with tradition. The Naturland brand is present in the most important part of people s life: in health and healthcare. An essential element of self-care and disease prevention is trust. During the production of its products, Naturland puts a significant emphasis on maintaining the well-established trust and the recognition of its brand. Naturland carries out full scale pharmaceutical manufacturing activities, ranging from research and development, through product licensing and production, to an independent pharmaceutical wholesale activity. For the production of its ointments, solutions, tablets, suppositories, ophthalmic stock solutions and for the packaging of pharmaceutical raw materials, the company has pharmaceutical manufacturing licenses and a license for the independent wholesale of pharmaceuticals and medicinal products. In addition to pharmacies - serviced and supplied by Naturland s own sales representatives and delivery fleet - the company s products are also delivered to drugstores, independent herbal stores and domestic, international FMCG retail partners. The company s three decades of accumulated knowledge in development and production of more than 400 registered medicines, pharmaceutical ingredients, dietary supplements, cosmetics, and tea variations are made available to its domestic and international pharmaceutical partners through its contract manufacturing services. The fundamental strategic goal of the company is autonomy and independence, which ensures a high degree of adaptability and flexibility to maintain its ability to quickly respond to the ever-changing market environment.
Listed securities of the issuer
Name Ticker ISIN
Naturland Holding Nyrt. A share NATURLAND HU0000199740
Download Trading Data
Show trades
Basic Information
Ticker NATURLAND
ISINHU0000199740
Date of listing09 Sep 2022
Currency of tradingHUF
Face Value100 HUF
Number of securities listed13,816,050
Market Capitalisation (HUF million)36,474
P/BV
P/BV* 13.0291
* Calculating based on the capitalisation of the actual series only
Performance
* annualized yield

Key annual data

audited, consolidated, in compliance with has; Business Year: January 1 - December 31
20221 20232
(thousand HUF) (thousand HUF)
Total revenues 5,192,421 5,587,992
Operating Profit (EBIT) 1,270,532 1,191,154
Net income from financial activities 75,458 29,245
Profit before tax 1,345,990 1,220,399
Profit after tax 1,279,6263 1,150,7934
Dividend per (ordinary) share 72.74 HUF 69.64 HUF
Fixed Assets 2,245,126 2,188,002
Total liabilities 1,486,638 1,158,733
Share capital 1,411,605 1,411,605
Shareholders equity 3,149,7893 3,195,6034
Total assets 4,688,768 4,529,648
Number of employees (at business year end) 171 153
(1) Audited, consolidated, (Business Year: January 1 - December 31)
(2) audited, consolidated, in compliance with has; Business Year: January 1 - December 31
(3) Auditált, konszolidált
(4) auditált, konszolidált
Download in Excel format Latest Annual Report

Selected financial ratios

Ratios are based on data submitted by the company
2022 2023
Equity Ratio 0.47 0.36
Return on assets (ROA) 0.41 0.36
Return on equity (ROE) 0.27 0.25
Download in Excel format

Mid-year reports

non-audited, consolidated, in compliance with has; Business Year: January 1 - June 30
Key P&L Figures Jan 2023 - Jun 20231 Jan 2024 - Jun 20241
(thousand HUF) (thousand HUF)
Net sales 2,645,461 2,943,030
Operating profit (EBIT) 562,299 687,055
Net income from financial activities 30,713 15,494
Profit before tax 593,021 702,549
Profit after tax 545,057 665,975
Key Balance Sheet Items 30 Jun 2023 30 Jun 2024
(thousand HUF) (thousand HUF)
Fixed Assets 2,212,508 2,170,724
Intangible Assets 22,512 28,287
Tangible assets 2,189,996 2,142,437
Invested financial assets 0 0
Current Assets 1,796,342 1,927,899
Inventory 1,092,379 1,090,514
Total assets 4,044,504 4,124,210
Shareholders equity 2,589,867 2,799,428
Share capital 1,411,605 1,411,605
Long-term liabilities 371,561 326,100
Short-term liabilities 758,682 627,271
Total liabilities and shareholders equity 4,044,504 4,124,210
(1) non-audited, consolidated, in compliance with has; Business Year: January 1 - June 30
Download in Excel format Latest half-yearly/quarterly report
Shareholders exceeding 5% stake with respect to the listed series
Name Shareholding (%) Share piece
Emil SZÁNTÓ 60.54 8,364,630
Pharmacash Kft. 32.64 4,509,828
Confido Treasury Kft. 6.51 900,000
Free Float: 0.31% Last update: 23 May 2024
Note: When determining the Free Float for a particular series, all the securities of the company shall be regarded to be publicly held other than (i) the stock of securities held by holders with direct holdings of more than 5% of the total number of securities, (ii) securities in the possession of custodians, provided the certificate available to the custodian verifies that the particular person holds more than 5% of the total number of securities outstanding belonging to the series. The value of the free float is based on the data provided by the issuer.
Management
Management Board ÁSVÁNYI Tibor Zoltán (Chairman), KURUCZ Mária, CZIRBUS Zoltán, ZÁMBÓ Gábor
Management ÁSVÁNYI Tibor Zoltán (Chairman of the Board), KURUCZ Mária (Board Member), CZIRBUS Zoltán (Board Member), ZÁMBÓ Gábor (Board Member)
Supervisory Board HAJDU László (Chairman of the Supervisory Board), SIPOS Krisztina, KISS Bence Botond
Last update: 18 Oct 2024
Publication Report
16 May 2025 12:02 Naturland Holding Nyrt. - Éves Jelentés
27 Sep 2024 14:35 Naturland Holding Nyrt. - Féléves jelentés
16 May 2025 11:58 Naturland Holding Nyrt. - FT jelentés
Publication Articles of Association
22 May 2025 17:16 Naturland Holding Nyrt. - Alapszabály
Publication Voting rights, registered capital
31 May 2025 17:50 Szavazati jogok, alaptőke
Further publications by the issuer Further publications of issuers
/pfile/file?path=/site/Angol/Documents/ker_ido_EN_02032015.pdf
/pfile/file?path=/site/Angol/Documents/link_6_fejezetEN.pdf
/pfile/file?path=/site/Angol/Documents/BSE_Release_certificates.pdf
/pfile/file?path=/site/Magyar/Dokumentumok/Kereskedesi_adatok/Links/xtend_ausz_hatalyos_2018_12_04_10fejezet
Name of securityNaturland Holding Nyrt. A share
IssuerNaturland Holding Public Company Limited by Shares
Equity classOrdinary share
Type of securityRegistered
Form of securityDematerialised
Code of security (ISIN)HU0000199740
Ticker symbolNATURLAND
Face value100 HUF
Number of securities listed13,816,050
Rights to dividendsFull year
Listing date09 Sep 2022
First Trading Day26 Sep 2022
Trading Unit
Currency of tradingHUF
Trading time
Listing price800
Date of Issue07 Jul 2022